Abstract:Background: With the improvement of people's living standards, the aging population in China has gradually increased, and the treatment of osteoporosis (OP) has become a major problem afflicting the medical field. Radix Astragali(RA) and Prepared Radix Rehmannia(PRR) are commonly used Chinese herbal medicines. The combination of them can achieve a synergistic effect in the treatment of osteoporosis. However, its mechanism of action remains uncertain.Objective: This study aims to investigate the possible molecular mechanism of RA combined with PRR in the treatment of OP using an integrated strategy of network pharmacology and experimental validation.Methods: The active ingredients of RA combined with PRR were searched and screened by TCMSP database, and the targets of active ingredients were predicted and supplemented by TCMSP and SwissTargetPrediction databases. The target genes related to OP diseases were searched in GeneCards and OMIM comprehensive databases. The intersection targets of drugs and diseases were imported into String database to obtain the interaction information of intersection target genes. Cytoscape3.7.1 software was used to construct the protein interaction network diagram and "drug component-target-disease" network diagram. Then DAVID database was used for GO gene enrichment analysis and KEGG metabolic pathway analysis. Finally, in vivo experiments were also performed to validate the findings of network pharmacology.Results: A total of 98 active components of RA combined with PRR were finally retrieved and integrated into the TCMSP database, 1700 target genes related to OP were obtained through the disease database, 149 gene targets were obtained by taking the intersection of disease genes, and drug targets, 122 core targets and 514 interaction relationships were obtained after protein interaction network and topology analysis. GO analysis and KEGG pathway enrichment analysis showed that RA combined with PRR intervention for OP mainly through multiple pathways such as PI3K-Akt, MAPK, TNF, Rap1, and Toll-like receptors. In addition, in vivo experiments confirmed that RA combined with PRR could significantly increase bone mineral density, reduce bone spacing, improve bone tissue structure, and improve osteoporosis in ovariectomized rats.Conclusion: In this study, the network pharmacological approach was used to reveal the potential targets and key signal pathways of RA combined with PRR in treating osteoporosis. This study was also verified by animal experiments, which provided a reliable basis for clinical application.

Network pharmacology-based investigation on the mechanisms of action of Morinda officinalis How. in the treatment of osteoporosis

Erxian decoction potentially prevents postmenopausal osteoporosis by modulating miR-335: a study based on bioinformatics analysis and preliminary clinical case validation

Integration of Zebrafish Model and Network Pharmacology to Explore Possible Action Mechanisms of Morinda officinalis for Treating Osteoporosis

The Underlying Mechanism of Chinese Herb of Regulating Marrow in the Treatment of Osteonecrosis of the Femoral Head Based on Network Pharmacology and Molecular Docking

Molecular mechanism of Achyranthis bidentatae radix and Morindae officinalis radix in osteoporosis therapy: An investigation based on network pharmacology, molecular docking, and molecular dynamics simulations

Prediction of the Molecular Mechanism of Corni Fructus-Epimedii Folium- Rehmanniae Radix Praeparata in the Treatment of Postmenopausal Osteoporosis Based on Network Pharmacology and Molecular Docking.

Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology

Mechanisms of action and synergetic formulas of plant-based natural compounds from traditional Chinese medicine for managing osteoporosis: a literature review

miRNA-Gene Interaction Network Construction Strategy to Discern Promising Traditional Chinese Medicine against Osteoporosis

Network Pharmacological Study on Mechanism of the Therapeutic Effect of Modified Duhuo Jisheng Decoction in Osteoporosis

A Network Pharmacology Approach to Explore and Validate the Potential Targets of Ginsenoside on Osteoporosis.

Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology

Based on Network Pharmacology to Explore the Mechanisms of Radix Astragali Combined with Prepared Radix Rehmanniain for Treating Osteoporosis

Use of Network Pharmacology and Molecular Docking Methods to Elucidate the Curative Effect of Epimedium–Anemarrhen on Osteoporosis

Potential mechanism of Ziyin Tongluo Formula in the treatment of postmenopausal osteoporosis: based on network pharmacology and ovariectomized rat model

Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate Osteoporosis

Metabolomics Profiling Provides Valuable Insights into the Underlying Mechanisms of Morinda Officinalis on Protecting Glucocorticoid-Induced Osteoporosis.

Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation

The Bioactive Compounds of Epimedium and Their Potential Mechanism of Action in Treating Osteoporosis: A Network Pharmacology and Experimental Validation Study

Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis

Investigation of inulins from the roots of Morinda officinalis for potential therapeutic application as anti-osteoporosis agent